Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements
(RTTNews) - Healthcare technology company Medtronic plc (MDT) announced Thursday it filed a complaint with the U.S. International Trade Commission (ITC), along with a parallel action in U.S. District Court for the District of Delaware, to block Axonics, Inc. (AXNX) from improperly importing and selling products that infringe two Medtronic patents related to the MRI compatibility of implantable medical devices.
Medtronic said Axonics uses Medtronic technologies to improperly compete in the market. It is profiting off of their unauthorized use of Medtronic's innovations and intellectual property.
Medtronic is asking the ITC to investigate and exclude the importation of the infringing Axonics products into the United States.
Medtronic currently has a separate infringement suit pending in the U.S. District Court for the Central District of California in which it asserts that Axonics has infringed additional technologies developed by and belonging to Medtronic.
Medtronic Guides FY25 Adj. EPS In Line With Estimates; Boosts Dividend - Update
Medtronic Boosts FY24 Outlook - Update
Boston Scientific To Acquire Axonics For $71/shr In All-cash Deal Valued At About $3.7 Bln
Medtronic Says Inceptiv Spinal Cord Stimulator With Closed-loop Sensing Gets CE Mark Approval
Medtronic Guides FY24 Adj. EPS Below View: Boosts Dividend - Update
Medtronic Boosts FY23 Adj. EPS Outlook - Update
Medtronic Reiterates FY23 Outlook - Update
